Thursday, 18 July 2024


Genetic Technologies appoints permanent CEO

11 December 2012 | News | By BioSpectrum Bureau

Ms Alison Mew has accepted the position of Genetic Technologies' permanent CEO

Ms Alison Mew has accepted the position of Genetic Technologies' permanent CEO

Singapore: The board of Genetic Technologies (GTG) has appointed Ms Alison Mew as the permanent chief executive officer of the company. The board also appointed Mr Ben Silluzio as a non-executive director of the company. Ms Alison Mew, who was GTG's COO, had been been appointed as acting CEO during November end, following the resignation of Dr Paul MacLeman. 

GTG's recently appointed chairman, Dr Mal Brandon, while speaking about Ms Mew's appointment, said that, "The board is extremely pleased that Ms Mew has accepted the company's offer to become its permanent CEO. In her previous role as GTG's chief operating officer, a position she held for more than three years, she played a key role in the establishment of the group's US operations along with securing the Australian laboratory's US compliance. We are confident that she is well placed to lead the company through its next stages of development in both the Australian and US markets." 

Mr Silluzio, 36, specializes in the provision of advice for sophisticated investors, institutional clients and high net worth families in Melbourne, nationally and abroad. Currently, he serves as the managing partner and desk head of RBS Morgans Family Office, and is also a director of Private Branded Beverages, a public unlisted company, and is a former president and chairman of the Italian Chamber of Commerce.

Previously, Mr Silluzio has held several senior positions in the stockbroking and funds management industries, including, director of UBS Wealth Management Australia, senior vice president of Credit Suisse First Boston in Melbourne, vice president and member of the Smith Barney Century Council at Citigroup Smith Barney in Melbourne and as an institutional client advisor at Colonial Institutional Stockbroking in Sydney and Melbourne.

Dr Mal Brandon, while speaking about Mr Silluzio's appointment, said that, "The board is also pleased to welcome Mr Silluzio to the company's board. We are confident that he will bring valuable skills, contacts and experience which will assist the company to expand its profile with the wider investment community."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account